Followers | 0 |
Posts | 1744 |
Boards Moderated | 0 |
Alias Born | 03/25/2018 |
Monday, September 16, 2019 3:31:51 PM
Today 3:18 PM ET (MarketWatch)
Share
By Tomi Kilgore, MarketWatch
Stifel Nicolaus turns bearish, slashes price target in wake of 'bad' quarterly results
Aurora Cannabis Inc. shares tumbled Monday after Stifel Nicolaus analyst Andrew Carter told clients it was time to sell, noting that though the headlines of the Canada-based cannabis company's latest quarterly report were bad, the details of the results were even worse.
Carter downgraded Aurora's stock (http://www.marketwatch.com/story/aurora-cannabis-stock-falls-after-stifel-says-sell-slashes-price-target-2019-09-16) to sell, a little more than three months after initiating coverage with a hold rating (http://www.marketwatch.com/story/cannabis-sector-resumes-selloff-as-investors-shrug-off-bullish-canopy-note-2019-06-06). He slashed his price target on the Canada-listed stock to C$5, which is 31% below current levels from C$7.
The Canada-listed shares(ACB.T) shed 7.4%, while the U.S.-listed shares(ACB.T) slumped 7.5% in active morning trading. Volume in the U.S.-listed stock topped 29.3 million shares at around 3:15 p.m. Eastern, compared with the full-day average of about 13.3 million shares, according to FactSet data.
Aurora reported last week a wider-than-expected fiscal fourth-quarter loss and revenue that missed lowered expectations, sending the stock tumbling over 9% last Thursday. See Cannabis Watch (http://www.marketwatch.com/search).
Don't miss: Aurora Cannabis stock drops after earnings, as pot sales miss revised target (http://www.marketwatch.com/story/aurora-cannabis-stock-drops-after-earnings-miss-2019-09-11).
Stifel's Carter helped weigh on the stock immediately after the results by saying he believed the stock would remain under pressure given expectations that it would need to access the capital markets for a "significant ask (http://www.marketwatch.com/story/aurora-cannabis-stock-to-be-pressured-by-need-for-significant-capital-raise-analyst-says-2019-09-12)" to fund its aggressive growth plans.
But Carter said on Monday that Aurora's efforts to tap the capital markets will be "challenged" given the "overwhelmingly negative investor sentiment" towards the cannabis sector, damaged credibility and limited near-term catalysts to drive investor enthusiasm.
Also read: Cannabis companies are having a horrible summer as scandals mount and stocks slide (http://www.marketwatch.com/story/cannabis-companies-are-having-a-horrible-summer-as-scandals-mount-and-stocks-slide-2019-07-25).
'The headlines were bad, the details were worse'
In a note titled "The headlines were bad, the details were worse: Downgrade to sell" on Monday, Carter said the fourth-quarter results point to a "less robust in-market performance" and difficulty to continue positioning for the larger global opportunity.
"Our outlook suggests significant downside potential for the shares of Aurora over the near term, given it will be difficult for the company to continue positioning for the larger global opportunity within the confines of significant financing risk that could challenge the company's ability to fully embrace the level of investment needed to be a leader not only in the global cannabis category but also in Canada," Carter wrote.
He said he believes the company will remain challenged until it can attract an investment from a consumer partner.
Carter's call for a consumer partner comes after Corona-beer parent Constellation Brands Inc(STZ) made a $4 billion investment last year in Canopy Growth Corp (http://www.marketwatch.com/story/canopy-growth-is-at-the-top-of-the-food-chain-as-canada-gears-up-for-legal-weed-2018-08-29).(WEED.T) (WEED.T) , which led to the ousting of high-profile co-Chief Executive Bruce Linton (http://www.marketwatch.com/story/canopy-growth-stuns-with-news-that-co-ceo-bruce-linton-is-stepping-down-2019-07-03), and after cigarette seller Altria Group Inc.(MO) said it would pay the equivalent of $1.8 billion (http://www.marketwatch.com/story/cannabis-stock-cronos-soars-24-as-altria-takes-major-stake-2018-12-07) for a 45% stake in Cronos Corp.(CRON.T) (CRON.T)
See related: Canopy Growth's remaining CEO talks about pot company's shake-up, and the search for his replacement (http://www.marketwatch.com/story/canopy-growths-remaining-ceo-talks-about-pot-companys-shake-up-and-the-search-for-his-replacement-2019-09-09).
Carter said Aurora will likely have trouble competing with rivals Canopy Growth and Cronos in the global cannabis market until it can tout a partnership with a well-established and vested consumer partner. While those partnerships helped provide significant capital "de-risking" for Canopy Growth and Cronos, the risk has increased for Aurora given the recent volatility in the equity markets and uncertainty over Aurora's willingness and ability to attract a partner.
"Aurora has given mixed commentary on pursuing partnerships, but we believe the company will be required to continue pursuing an independent path with global consumer companies likely taking a wait-and-see approach to the sector with less incentive to partner with a Canadian L.P.," Carter wrote.
Aurora's stock has tumbled 27% over the past three months, while the ETFMG Alternative Harvest exchange-traded fund(MJ) has slumped 21% and the S&P 500 index has gained 3.9%.
-Tomi Kilgore; 415-439-6400; AskNewswires@dowjones.com
(END) Dow Jones Newswires
September 16, 2019 15:18 ET (19:18 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
Recent ACB News
- Aurora Improves Offerings in Australia with New Range of Premium Dried Flower Products • PR Newswire (US) • 04/30/2024 11:15:00 AM
- Aurora Improves Offerings in Australia with New Range of Premium Dried Flower Products • PR Newswire (Canada) • 04/30/2024 11:15:00 AM
- Marijuana Stocks Up After Banking Reform Progress • IH Market News • 04/09/2024 10:05:42 AM
- Aurora Cannabis Commends Germany's Landmark Legalization Achievement • PR Newswire (US) • 04/01/2024 11:00:00 AM
- Aurora Cannabis Commends Germany's Landmark Legalization Achievement • PR Newswire (Canada) • 04/01/2024 11:00:00 AM
- Aurora Cannabis Achieves Australia's TGA GMP Certification, Setting Global Standard for Quality and Compliance • PR Newswire (Canada) • 03/20/2024 11:15:00 AM
- Aurora Cannabis Achieves Australia's TGA GMP Certification, Setting Global Standard for Quality and Compliance • PR Newswire (US) • 03/20/2024 11:15:00 AM
- Aurora Introduces Medical Cannabis Pastilles for Patient Relief in Australia • PR Newswire (Canada) • 03/04/2024 02:42:00 PM
- Aurora Introduces Medical Cannabis Pastilles for Patient Relief in Australia • PR Newswire (US) • 03/04/2024 02:42:00 PM
- Aurora Completes Final Repayment of Convertible Senior Notes Representing ~$465 Million in Total Repayments Since 2021; Cannabis Operations Are Now Debt Free[1] • PR Newswire (Canada) • 02/29/2024 10:00:00 PM
- Aurora Completes Final Repayment of Convertible Senior Notes Representing ~$465 Million in Total Repayments Since 2021; Cannabis Operations Are Now Debt Free[1] • PR Newswire (US) • 02/29/2024 10:00:00 PM
- Aurora Partners with Script Assist to Provide Better Access to UK Medical Cannabis • PR Newswire (US) • 02/28/2024 12:13:00 PM
- Aurora Partners with Script Assist to Provide Better Access to UK Medical Cannabis • PR Newswire (Canada) • 02/28/2024 12:11:00 PM
- Aurora Partners with Script Assist to Provide Better Access to UK Medical Cannabis • PR Newswire (US) • 02/28/2024 12:11:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/20/2024 12:36:30 PM
- Aurora Cannabis Announces CFO Transition and Completion of Previously Announced Share Consolidation • PR Newswire (Canada) • 02/20/2024 12:00:00 PM
- Aurora Cannabis Announces CFO Transition and Completion of Previously Announced Share Consolidation • PR Newswire (US) • 02/20/2024 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/16/2024 02:49:18 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/08/2024 12:23:28 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/08/2024 12:10:27 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/08/2024 12:07:18 PM
- Aurora Cannabis Announces Fiscal 2024 Third Quarter Results; Generates Record Adjusted EBITDA of $4.3 Million • PR Newswire (Canada) • 02/08/2024 12:00:00 PM
- Aurora Cannabis Announces Fiscal 2024 Third Quarter Results; Generates Record Adjusted EBITDA of $4.3 Million • PR Newswire (US) • 02/08/2024 12:00:00 PM
- Aurora Cannabis Acquires MedReleaf Australia • PR Newswire (US) • 02/08/2024 11:45:00 AM
- Aurora Cannabis Acquires MedReleaf Australia • PR Newswire (Canada) • 02/08/2024 11:45:00 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM